Former CDC Director Redfield Questions Russian Plague Case

Former Centers for Disease Control and Prevention (CDC) director Dr. Robert Redfield has voiced concerns that the suspected plague case in Russia could involve a "manipulated" strain of the disease. Redfield, who led the CDC at the beginning of the COVID-19 pandemic, told NewsNation that the aggressive response by Russian authorities, including the closure of five hospitals and the isolation of over 200 people, seems disproportionate for a typical pneumonic plague infection.

"That's not pneumonic plague. It doesn't make sense to me that this was wild-type plague," Redfield stated, suggesting that a lab worker contracting the disease would typically be treated with antibiotics within 24 hours of exposure if working with a standard strain. He speculated that if the plague strain had been engineered to be resistant to antibiotics, it could explain why treatment might have been ineffective.

Concerns were amplified last week when reports emerged of Darya Shipilova, a 28-year-old lab worker at the Irkutsk Anti-Plague Research Institute in Siberia, who allegedly broke a test tube containing live plague bacteria. Russian officials have stated Shipilova died from an "unidentified pneumonia," noting that her colleagues had symptoms consistent with COVID-19 and the common cold. However, local media reports and statements from local officials suggest she may have been infected with pneumonic plague, a highly contagious and potentially fatal form of the disease.

There is currently no evidence to confirm that Shipilova was infected with a manipulated strain of the plague. Shipilova was hospitalized on September 29 and died on October 2. It remains unclear if she received antibiotics. Russian epidemiologist Mikhail Favorov suggested that misidentification of the infection by doctors was possible, as plague cases are rare in the region.

Conflicting reports exist regarding the circumstances of her illness. Some local media suggest she contracted an infection after an accident in the lab, while others indicate she fell ill after a work trip to Buryatia, a region known to harbor plague bacteria. Local media has also reported a second suspected death from plague in the Irkutsk region, though this has not been officially confirmed.

President Donald Trump, following a call with Russian President Vladimir Putin, expressed confidence that the case was not caused by a manipulated strain but added, "We're going to find out." He stated that Russian officials assured him the situation was "very much under control."

Speaking at a health summit in Washington D.C., CDC director Erica Schwartz described the threat to the U.S. from the suspected outbreak as "extremely low." In response to fears of the potential spread, some countries bordering Russia have increased health screenings. The U.S. Embassy in Moscow has renewed its advisory for U.S. citizens to depart Russia immediately due to security concerns and the risk of wrongful detention.

The World Health Organization and other international health bodies have requested more information from Russia regarding the suspected plague case. The Irkutsk research facility has historical ties to Soviet-era military research, and during the 1970s and 1980s, Soviet scientists reportedly studied natural plague strains for potential military applications. Dr. Ken Alibek, a former researcher in Russia's germ-warfare program, has previously stated that the Soviet Union worked on creating antibiotic-resistant plague strains for bioweapons.

Pneumonic plague, the most dangerous form of the disease, infects the lungs and can be spread through respiratory transmission, though sustained face-to-face contact is typically required. The infection is usually treatable with antibiotics if administered early. Globally, approximately 1,000 to 2,000 plague cases are recorded annually, with transmission occurring through flea bites or handling infected animal carcasses. While plague is endemic in parts of Russia's Far East, and cases have been reported in Mongolia and the U.S., the specific strain and circumstances of the Irkutsk case remain under scrutiny.